Thyroid Emergencies: A Narrative Review.

IF 3.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Margaret L Kruithoff, Benjamin J Gigliotti
{"title":"Thyroid Emergencies: A Narrative Review.","authors":"Margaret L Kruithoff, Benjamin J Gigliotti","doi":"10.1016/j.eprac.2025.06.010","DOIUrl":null,"url":null,"abstract":"<p><p>Myxedema coma and thyroid storm are rare thyroid emergencies associated with considerable mortality and morbidity. Myxedema coma is a state of decompensated hypothyroidism with widespread multi-organ dysfunction, most notably impaired consciousness, mixed respiratory failure, and hypothermia. Thyroid storm is the extreme state of thyrotoxicosis occurring when a patient's metabolic, thermoregulatory, and cardiovascular compensatory mechanisms are surpassed. Common clinical features of thyroid storm include hyperthermia, neuropsychiatric symptoms, and tachyarrhythmias. Thyroid emergencies usually result from a precipitating event or trigger transforming a previously compensated hypothyroid or thyrotoxic state. The diagnosis of myxedema coma and thyroid storm is established from clinical features in the either already hypothyroid or thyrotoxic patient. In the case of thyroid storm, clinicians may augment their clinical reasoning with the Japanese Thyroid Association Diagnostic Criteria or the Burch-Wartofsky Point Scale. Supportive care for the cardiovascular, respiratory, and thermoregulatory manifestations, as well as possible intercurrent illness or adrenal insufficiency, play a lead role in the management. For myxedema coma, treatment typically includes high dose levothyroxine with the addition of liothyronine for critically ill patients. Management of thyroid storm is multi-pronged and stepwise, consisting of first-line thionamide and beta-adrenergic receptor antagonist therapy as first-line, inorganic iodine, as well as cholestyramine, plasmapheresis, or emergent thyroidectomy in appropriate severely ill patients.</p>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eprac.2025.06.010","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Myxedema coma and thyroid storm are rare thyroid emergencies associated with considerable mortality and morbidity. Myxedema coma is a state of decompensated hypothyroidism with widespread multi-organ dysfunction, most notably impaired consciousness, mixed respiratory failure, and hypothermia. Thyroid storm is the extreme state of thyrotoxicosis occurring when a patient's metabolic, thermoregulatory, and cardiovascular compensatory mechanisms are surpassed. Common clinical features of thyroid storm include hyperthermia, neuropsychiatric symptoms, and tachyarrhythmias. Thyroid emergencies usually result from a precipitating event or trigger transforming a previously compensated hypothyroid or thyrotoxic state. The diagnosis of myxedema coma and thyroid storm is established from clinical features in the either already hypothyroid or thyrotoxic patient. In the case of thyroid storm, clinicians may augment their clinical reasoning with the Japanese Thyroid Association Diagnostic Criteria or the Burch-Wartofsky Point Scale. Supportive care for the cardiovascular, respiratory, and thermoregulatory manifestations, as well as possible intercurrent illness or adrenal insufficiency, play a lead role in the management. For myxedema coma, treatment typically includes high dose levothyroxine with the addition of liothyronine for critically ill patients. Management of thyroid storm is multi-pronged and stepwise, consisting of first-line thionamide and beta-adrenergic receptor antagonist therapy as first-line, inorganic iodine, as well as cholestyramine, plasmapheresis, or emergent thyroidectomy in appropriate severely ill patients.

甲状腺急症:叙述性回顾。
黏液性水肿昏迷和甲状腺风暴是罕见的甲状腺急症,具有相当高的死亡率和发病率。黏液性水肿昏迷是一种失代偿性甲状腺功能减退伴广泛多器官功能障碍的状态,最明显的是意识受损、混合性呼吸衰竭和体温过低。甲状腺风暴是甲状腺毒症的极端状态,当患者的代谢、体温调节和心血管代偿机制被超越时发生。甲状腺风暴的常见临床特征包括高热、神经精神症状和快速心律失常。甲状腺急症通常是由于突发事件或触发改变先前代偿的甲状腺功能减退或甲状腺中毒状态。黏液性水肿昏迷和甲状腺风暴的诊断是根据甲状腺功能低下或甲状腺中毒患者的临床特征建立的。在甲状腺风暴的情况下,临床医生可以用日本甲状腺协会诊断标准或Burch-Wartofsky积分量表来增强他们的临床推理。对心血管、呼吸和体温调节表现的支持治疗,以及可能的合并疾病或肾上腺功能不全,在治疗中起主导作用。对于黏液水肿昏迷,治疗通常包括重症患者高剂量左甲状腺素加碘甲状腺原氨酸。甲状腺风暴的治疗是多管齐下、循序渐进的,包括一线硫胺和β -肾上腺素能受体拮抗剂治疗,无机碘,以及胆甾胺、血浆置换,或在适当的重症患者紧急甲状腺切除术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine Practice
Endocrine Practice ENDOCRINOLOGY & METABOLISM-
CiteScore
7.60
自引率
2.40%
发文量
546
审稿时长
41 days
期刊介绍: Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信